Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12612000953831
Ethics application status
Approved
Date submitted
27/08/2012
Date registered
5/09/2012
Date last updated
21/01/2016
Type of registration
Prospectively registered

Titles & IDs
Public title
Can Heart Rate Variability analysis reduce analgesic requirements after laparoscopic cholecystectomy?
Scientific title
A randomised controlled pilot trial comparing the effectiveness of intraoperative Acute Nociception Index (ANI) monitoring on reducing moderate-severe pain in the Postanaesthesia Care Unit (PACU) in patients having elective cholecystectomy.
Secondary ID [1] 281101 0
Nil
Universal Trial Number (UTN)
U1111-1133-8409
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
cholecystectomy 287259 0
Condition category
Condition code
Anaesthesiology 287676 287676 0 0
Pain management

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Dose of intraoperative intravenous analgesia administration (morphine or fentanyl) based on measurement of autonomic tone using the Acute Nociception Index (ANI) monitor. The ANI monitor is a modified ECG monitor that uses a software algorthim to measure variation in the ECG R-R interval to generate an index for the patients autonomic tone. Dose ranges MORPHINE 3-5mg (give 5mg if ANI < 30), max cumulative dose 40mg (age<50), 30mg (age<75) OR FENTANYL 30-50mcg (give 50mcg if ANI < 30), max cumulative dose 400mcg (age<50), 300mcg (age<75)
Review ANI after 5 minutes and repeat bolus as above if ANI score remains below 50. Repeat after every 5 minutes until ANI score >50 (maximum morphine dose permitted 40mg if age<50, 30 mg if age 50-75- or fentanyl equivalent)
Intervention code [1] 285555 0
Treatment: Devices
Intervention code [2] 285623 0
Treatment: Drugs
Comparator / control treatment
Intervention group:, ANI score below 50:
a. MORPHINE 3-5mg (give 5mg if ANI < 30), max cumulative dose 40mg (age<50), 30mg (age<75)
OR
b. FENTANYL 30-50mcg (give 50mcg if ANI < 30), max cumulative dose 400mcg (age<50), 300mcg (age<75)
Review ANI every 5 minutes and bolus as per above.
Comparator group: usual practice. i.e. Intraoperative analgesia administration (morphine of fentanyl) in doses based on clinician experience and training, based on usual clinical practice (e.g. increase heart rate,increased blood pressure, etc). There are no protocols to guide this. Maximum doses as above.
Control group
Active

Outcomes
Primary outcome [1] 287848 0
Proportion with severe pain (Visual Analogue Scale >5 ) in PACU
Timepoint [1] 287848 0
1 hour
Secondary outcome [1] 298931 0
Sum of pain scores (Visual Analogue Scale) at 15, 30, 45 and 60 minutes in recovery room
Timepoint [1] 298931 0
1 hour
Secondary outcome [2] 298932 0
Total amount of rescue Morphine/Fentanyl protocol in PACU in mg. PACU opioid pain protocol is based on clinical assessment of patients pain i.e VAS score 3-5 give morphine 1mg, reassess after 5 minutes, VAS pain score >5 give 3mg morphine, reassess after 5 minutes.
Timepoint [2] 298932 0
1 hour

Eligibility
Key inclusion criteria
Elective laparoscopic cholecystectomy
Minimum age
18 Years
Maximum age
74 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Inability to obtain informed consent from patient
Cognitively impaired patients
Emergency cholecystectomy
Non-sinus rhythmn cardiac status
Known impairment of the autonomic nervous system
Pregnancy

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Eligible participant will be identified from the elective surgical operating list. Informed written consent will be sought from the patient on the day of surgery by an investigator, or by the anaesthetist / anaesthetic registrar.
Randomisation to a treatment group will be determined in advance (blocked random allocation) and concealed by means of sealed, opaque and tamper-proof envelopes.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Blocked random allocation by the trial statistician
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 4
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/10/2012
Actual
1/10/2012
Date of last participant enrolment
Anticipated
Actual
9/09/2013
Date of last data collection
Anticipated
Actual
Sample size
Target
100
Accrual to date
Final
120
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 285887 0
Hospital
Name [1] 285887 0
Peninsula Health
Country [1] 285887 0
Australia
Primary sponsor type
Hospital
Name
Peninsula Health (Frankston Hospital)
Address
Hastings Rd
Frankston VIC 3199
Country
Australia
Secondary sponsor category [1] 284712 0
None
Name [1] 284712 0
Address [1] 284712 0
Country [1] 284712 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 287917 0
Peninsula Health HREC
Ethics committee address [1] 287917 0
Ethics committee country [1] 287917 0
Australia
Date submitted for ethics approval [1] 287917 0
22/08/2012
Approval date [1] 287917 0
03/09/2012
Ethics approval number [1] 287917 0
HREC/12/PH/65

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 34627 0
Dr Joshua Szental
Address 34627 0
Department of Anaesthesia
Peninsula Health
Frankston VIC 3199
Country 34627 0
Australia
Phone 34627 0
+61397847445
Fax 34627 0
Email 34627 0
jszental@gmail.com
Contact person for public queries
Name 17874 0
Dr Ashley Webb
Address 17874 0
Department of Anaesthesia
Peninsula Health
Hastings Rd
Frankston VIC 3199
Country 17874 0
Australia
Phone 17874 0
+61397847445
Fax 17874 0
+61397847441
Email 17874 0
awebb@phcn.vic.gov.au
Contact person for scientific queries
Name 8802 0
Dr Ashley Webb
Address 8802 0
Department of Anaesthesia
Peninsula Health
Hastings Rd
Frankston VIC 3199
Country 8802 0
Australia
Phone 8802 0
+61397847445
Fax 8802 0
+61397847441
Email 8802 0
awebb@phcn.vic.gov.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbasePostoperative pain after laparoscopic cholecystectomy is not reduced by intraoperative analgesia guided by analgesia nociception index (ANI) monitoring: A randomized clinical trial.2015https://dx.doi.org/10.1093/bja/aeu411
N.B. These documents automatically identified may not have been verified by the study sponsor.